Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") today announced financial results for the third quarter and nine-month period ended September 30, 2024. Highlights ...

Announced promising safety and positive biomarker data from Cohort 2 (5mg BID) of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients demonstrating dose dependent ...

Jung Ha-yun is a writer and translator whose work has appeared in The New York Times, Best New American Voices, Translation ...

Korea.net reporters and Seoul-based correspondents for 10 foreign media outlets including The Yomiuri Shimbun and Jiji Press ...

The Toronto Maple Leafs have activated defenseman Jani Hakanpaa from long term injured reserve and recalled him from his ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

High-dose LTI-03 (5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both ...

Danny Belton, head of lending at MAB, said: “In a market that’s hungry for innovation, we’re delighted to welcome April ...

Billionaire Bruce Mathieson has lashed out at the board and management of embattled pubs and bottle shops giant Endeavour ...

Aileron Therapeutics (ALRN) announced positive topline data from Cohort 2 of its Phase 1b clinical trial evaluating the safety and tolerability ...

"The Literature Translation Institute (LTI) of Korea strives to make a big leap as a bridgehead to globally promote the depth ...